These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Metcalfe MJ; Ferguson JE; Li R; Xiao L; Guo CC; Czerniak BA; Siefker-Radtke A; Pretzsch SM; Navai N; McConkey DJ; Kamat AM; Campbell M; Dinney C Eur Urol Focus; 2017 Dec; 3(6):577-583. PubMed ID: 28753816 [TBL] [Abstract][Full Text] [Related]
30. Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases. Mitra AP; Cai J; Miranda G; Bhanvadia S; Quinn DI; Schuckman AK; Djaladat H; Daneshmand S J Urol; 2022 Feb; 207(2):302-313. PubMed ID: 34994657 [TBL] [Abstract][Full Text] [Related]
31. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder. Hensley PJ; Goodwin J; Davenport DL; Strup SE; James A Clin Genitourin Cancer; 2018 Aug; 16(4):e851-e858. PubMed ID: 29548614 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Magers MJ; Kaimakliotis HZ; Barboza MP; Bandali E; Adra N; Koch MO; Cheng L J Clin Pathol; 2019 Aug; 72(8):550-553. PubMed ID: 31164444 [TBL] [Abstract][Full Text] [Related]
33. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y; Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010 [TBL] [Abstract][Full Text] [Related]
34. Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database. Darwish C; Sparks A; Amdur R; Reddy A; Whalen M Urology; 2020 Dec; 146():168-176. PubMed ID: 32866509 [TBL] [Abstract][Full Text] [Related]
35. Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy. von Landenberg N; Speed JM; Cole AP; Seisen T; Lipsitz SR; Gild P; Menon M; Kibel AS; Roghmann F; Noldus J; Sun M; Trinh QD Urol Oncol; 2018 Feb; 36(2):78.e13-78.e19. PubMed ID: 29169845 [TBL] [Abstract][Full Text] [Related]
36. Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy. D'Andrea D; Shariat SF; Soria F; DI Trapani E; Mertens LS; VAN Rhijn BW; Dinney CP; Black PC; Spiess PE; Carrion DM; Pradere B; Tonin E; Pichler R; Filippot R; Mari A; Moschini M; Minerva Urol Nephrol; 2023 Aug; 75(4):452-459. PubMed ID: 37314813 [TBL] [Abstract][Full Text] [Related]
37. Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer. Chappidi MR; Kates M; Brant A; Baras AS; Netto GJ; Pierorazio PM; Hahn NM; Bivalacqua TJ Urology; 2017 Apr; 102():148-158. PubMed ID: 28104421 [TBL] [Abstract][Full Text] [Related]
38. A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging. Audenet F; Sfakianos JP; Waingankar N; Ruel NH; Galsky MD; Yuh BE; Gin GE Urol Oncol; 2019 Feb; 37(2):116-122. PubMed ID: 30509868 [TBL] [Abstract][Full Text] [Related]
39. Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy. Cha EK; Sfakianos JP; Sukhu R; Yee AM; Sjoberg DD; Bochner BH BJU Int; 2018 Oct; 122(4):627-632. PubMed ID: 29633530 [TBL] [Abstract][Full Text] [Related]
40. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder. Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]